ExodusPoint Capital Management, LP

Position in AMRX — Amneal Pharmaceuticals, Inc.

CIK 1736225 NEW YORK, NY

Back to AMRX Full portfolio

Position in AMRX

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$2,009,931

-$8,397,656 QoQ

Shares Held

161,700

-80.4% QoQ

Ownership

0.051%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2021

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in AMRX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

ExodusPoint Capital Management, LP holds $58,166,201 across 15 Drug Manufacturers - Specialty & Generic names. AMRX ranks #7 (3.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LNTH	Lantheus Holdings, Inc.	216,322	$16,408,023
2	ELAN	Elanco Animal Health Inc	570,032	$13,640,865
3	SUPN	Supernus Pharmaceuticals, Inc.	202,116	$10,447,376
4	ALKS	Alkermes plc.	204,324	$7,224,896
5	KNSA	Kiniksa Pharmaceuticals International, plc	52,303	$2,518,389
6	PRGO	PERRIGO Co plc	190,050	$2,041,137
7	AMRX	Amneal Pharmaceuticals, Inc. This page	161,700	$2,009,931
8	BCRX	Biocryst Pharmaceuticals Inc	190,058	$1,809,352

All Filings in AMRX

Export CSV

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,009,931	161,700	-80.4%	Shares	Sole	2026-05-14
2025-12-31	$10,407,587	825,999	+11.2%	Shares	Sole	2026-02-17
2025-09-30	$7,435,558	742,813	+39.7%	Shares	Sole	2025-11-14
2025-06-30	$4,302,108	531,781	+391.2%	Shares	Sole	2025-08-13
2024-12-31	$857,474	108,267	-3.3%	Shares	Sole	2025-02-12
2024-06-30	$711,003	111,969	+135.8%	Shares	Sole	2024-08-13
2023-09-30	$200,382	47,484	+103.9%	Shares	Sole	2023-11-13
2021-12-31	$111,568	23,292	-44.6%	Shares	Sole	2022-02-11
2021-06-30	$215,203	42,032	—	Shares	Other	2021-08-16
No filing history on record for this holder in this stock.